![](/img/cover-not-exists.png)
Longterm Effect of Delaying Combination Therapy with Tumor Necrosis Factor Inhibitor in Patients with Aggressive Early Rheumatoid Arthritis: 10-year Efficacy and Safety of Adalimumab from the Randomized Controlled PREMIER Trial with Open-label Extension
Keystone, E. C., Breedveld, F. C., van der Heijde, D., Landewe, R., Florentinus, S., Arulmani, U., Liu, S., Kupper, H., Kavanaugh, A.Volume:
41
Language:
english
Journal:
The Journal of Rheumatology
DOI:
10.3899/jrheum.130543
Date:
January, 2014
File:
PDF, 1006 KB
english, 2014